This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1988;39(1-3):33-43.

doi: 10.1016/0163-7258(88)90037-x.

Specific protection of different normal tissues

J S Rasey¹, A M Spence, C C Badger, K A Krohn, D M Vera, J C Livesey

Affiliations

PMID: 2849132
DOI: 10.1016/0163-7258(88)90037-x

Review

Specific protection of different normal tissues

J S Rasey et al. Pharmacol Ther. 1988.

. 1988;39(1-3):33-43.

doi: 10.1016/0163-7258(88)90037-x.

Authors

J S Rasey¹, A M Spence, C C Badger, K A Krohn, D M Vera, J C Livesey

Affiliation

¹ Department of Radiation Oncology, University of Washington Medical School, Seattle.

PMID: 2849132
DOI: 10.1016/0163-7258(88)90037-x

No abstract available

PubMed Disclaimer

Similar articles

Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine.
Mell LK, Movsas B. Mell LK, et al. Expert Opin Drug Metab Toxicol. 2008 Oct;4(10):1341-50. doi: 10.1517/17425255.4.10.1341. Expert Opin Drug Metab Toxicol. 2008. PMID: 18798703 Review.
Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure.
Cassatt DR, Fazenbaker CA, Bachy CM, Kifle G, McCarthy MP. Cassatt DR, et al. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):901-7. doi: 10.1016/j.ijrobp.2004.10.032. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708273
Clinical status and optimal use of amifostine.
Capizzi RL. Capizzi RL. Oncology (Williston Park). 1999 Jan;13(1):47-59; discussion 63, 67. Oncology (Williston Park). 1999. PMID: 10027198 Review.
Pharmacokinetics of WR-2721.
Shaw LM, Glover D, Turrisi A, Brown DQ, Bonner HS, Norfleet AL, Weiler C, Glick JH, Kligerman MM. Shaw LM, et al. Pharmacol Ther. 1988;39(1-3):195-201. doi: 10.1016/0163-7258(88)90061-7. Pharmacol Ther. 1988. PMID: 2849123 Review. No abstract available.
Guidelines for the administration of amifostine.
Schuchter LM. Schuchter LM. Semin Oncol. 1996 Aug;23(4 Suppl 8):40-3. Semin Oncol. 1996. PMID: 8783665

See all similar articles

Cited by

Amifostine Suppresses the Side Effects of Radiation on BMSCs by Promoting Cell Proliferation and Reducing ROS Production.
Huang B, He T, Yao Q, Zhang L, Yao Y, Tang H, Gong P. Huang B, et al. Stem Cells Int. 2019 Jan 9;2019:8749090. doi: 10.1155/2019/8749090. eCollection 2019. Stem Cells Int. 2019. PMID: 30728842 Free PMC article.
THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.
Singh VK, Fatanmi OO, Wise SY, Newman VL, Romaine PL, Seed TM. Singh VK, et al. Radiat Prot Dosimetry. 2016 Dec;172(1-3):302-310. doi: 10.1093/rpd/ncw223. Epub 2016 Aug 19. Radiat Prot Dosimetry. 2016. PMID: 27542813 Free PMC article.
Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.
Singh VK, Romaine PL, Seed TM. Singh VK, et al. Health Phys. 2015 Jun;108(6):607-30. doi: 10.1097/HP.0000000000000279. Health Phys. 2015. PMID: 25905522 Free PMC article. Review.
Radiation countermeasure agents: an update (2011-2014).
Singh VK, Newman VL, Romaine PL, Wise SY, Seed TM. Singh VK, et al. Expert Opin Ther Pat. 2014 Nov;24(11):1229-55. doi: 10.1517/13543776.2014.964684. Epub 2014 Oct 14. Expert Opin Ther Pat. 2014. PMID: 25315070 Free PMC article. Review.
Amino acids and their derivatives as radioprotective agents.
Roberts JC. Roberts JC. Amino Acids. 1992 Feb;3(1):25-52. doi: 10.1007/BF00806007. Amino Acids. 1992. PMID: 24192988

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database